2021
DOI: 10.1089/lap.2021.0285
|View full text |Cite
|
Sign up to set email alerts
|

Managing Complex Perianal Fistulizing Disease

Abstract: Perianal disease is a particularly morbid phenotype of Crohn's disease, affecting up to one third of patients, with a significantly diminished quality of life. Conventional medical therapy and surgical interventions have limited efficacy. Medical treatment options achieve long-term durable remission in only a third of patients. Therefore, most patients undergo an operation, leaving them with a chronic seton or at risk of incontinence with multiple interventions. Mesenchymal stem cell therapy is an emerging the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 70 publications
0
3
0
Order By: Relevance
“…This is in keeping with other studies, which emphasize drainage of any abscesses and maintenance of the fistula tract with a loose seton. 19,20,22 Other surgical techniques such as fistulotomy, mucosal advancement flap, ligation of an intersphincteric fistula tract, or cone-like resection are reserved for specific scenarios on a case-by-case basis, and our institutional practice echoes this evidence. 23,[37][38][39][40] In our study, 22% of patients required fecal diversion (for perianal disease or persistent Crohn's disease), and only 15% of these patients had continuity restored.…”
Section: Discussionmentioning
confidence: 95%
See 1 more Smart Citation
“…This is in keeping with other studies, which emphasize drainage of any abscesses and maintenance of the fistula tract with a loose seton. 19,20,22 Other surgical techniques such as fistulotomy, mucosal advancement flap, ligation of an intersphincteric fistula tract, or cone-like resection are reserved for specific scenarios on a case-by-case basis, and our institutional practice echoes this evidence. 23,[37][38][39][40] In our study, 22% of patients required fecal diversion (for perianal disease or persistent Crohn's disease), and only 15% of these patients had continuity restored.…”
Section: Discussionmentioning
confidence: 95%
“…19 The historic healing rate of perianal fistulas in adult patients with Crohn's disease is 30%, but this rate is less clear in the pediatric population because of small sample sizes in prior case series. 10,11,20 In adults, first-line treatment includes surgical drainage of abscesses and control of fistula(s) with seton drains in combination with antibiotics, biologics, and immunomodulator therapies. [21][22][23][24] However, it is unclear whether the optimal strategy for perianal fistulas is the same for pediatric patients.…”
Section: Principales Medidas De Resultadomentioning
confidence: 99%
“…Although current treatments for PFs include a range of medical and surgical options, managing this condition is difficult. Patients with complex PFs tend to have poor treatment outcomes or experience frequent relapses, and most interventions are ineffective in providing long-term healing[ 7 - 10 ]. Immunomodulators can have serious side effects.…”
Section: Introductionmentioning
confidence: 99%